Hydrogiene & Medigard Update


SAN DIEGO, Calif., March 13, 2000 (PRIMEZONE) -- Charles Kallmann, President and CEO of Hydrogiene Corporation, reports the company is to receive its first "Medigiene" Microbiological disinfectant product within the next four to five weeks. This initial formulation to be tested for Hydrogiene by International Test Laboratories of Newark, New Jersey. First substrates tested for effectiveness of kill time limits will be wood, glass, china, stainless steel, and silverware.

Since testing of microbiological entities cannot be accelerated, the five substrates to be tested with Medigiene sprayed on/air dried materials are those with an anticipated two to four months effectiveness against the programmed infections components. Additional substrates with longer kill effectiveness timeframes will also start test routines, meaning that over the next two to three years as testing completes on each class of substrate it will be added to the list of materials covered by certified independent testing facilities as to their effectiveness and kill times.

"Killing microbiological entities such as: viruses, bacteria, and fungus are not necessarily difficult, Kallmann stated, keeping them killed over extended periods of time is the trick." Hydrogiene's world-wide patented protection chemical grafting process, with the addition of various disinfectant formulae funning the gamut from E-coli strains, Staf, Salmonella, HIV, Hepatitis B and a wide range of other such microbiologicals, enables the disinfection process to remain effective over extended periods of time, depending on the substrates applied to. "Truly a major technological breakthrough to the existing state-of-the-art disinfection process," Kallmann said.

Medigiene will be offered worldwide on a license basis, as well as, utilized by the company in its own Medicienze and Theraclenze product lines. "Medigiene will also be utilized by the company in its soon to be introduced line of lotions, creams, and salves," Kallman reported.

Kallman also added, Theraclenze and Mediclenze products are designed to meet U.S. state, federal and local plumbing codes, including IAPMO and UL test regimes designed to prevent backflow water contamination.

Safe Harbor for Forward-Looking Statements: Except for historical information contained herein, the statements in this new release are forward looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to differ from forecasted results.



            

Coordonnées